Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 14 | 2023 | 202 | 2.140 |
Why?
|
| Astrocytes | 11 | 2023 | 124 | 1.750 |
Why?
|
| beta Catenin | 12 | 2022 | 55 | 1.600 |
Why?
|
| HIV Infections | 13 | 2023 | 421 | 1.550 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2022 | 109 | 0.540 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2013 | 14 | 0.540 |
Why?
|
| Wnt Signaling Pathway | 4 | 2022 | 29 | 0.480 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 15 | 0.470 |
Why?
|
| Virus Latency | 2 | 2022 | 14 | 0.470 |
Why?
|
| Transcription Factors | 2 | 2014 | 149 | 0.440 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 61 | 0.410 |
Why?
|
| CD4 Antigens | 3 | 2022 | 29 | 0.390 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 60 | 0.370 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 27 | 0.370 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 229 | 0.330 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2023 | 50 | 0.320 |
Why?
|
| HIV Long Terminal Repeat | 4 | 2013 | 17 | 0.320 |
Why?
|
| TCF Transcription Factors | 4 | 2020 | 11 | 0.320 |
Why?
|
| Signal Transduction | 5 | 2017 | 393 | 0.300 |
Why?
|
| Brain | 3 | 2022 | 1123 | 0.260 |
Why?
|
| AIDS Dementia Complex | 2 | 2017 | 39 | 0.240 |
Why?
|
| Cells, Cultured | 6 | 2023 | 467 | 0.230 |
Why?
|
| Humans | 21 | 2023 | 22592 | 0.230 |
Why?
|
| CD8 Antigens | 2 | 2022 | 11 | 0.220 |
Why?
|
| Cell Movement | 2 | 2022 | 77 | 0.220 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 12 | 0.200 |
Why?
|
| Mice | 7 | 2023 | 1224 | 0.200 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 96 | 0.200 |
Why?
|
| Wnt Proteins | 2 | 2020 | 20 | 0.190 |
Why?
|
| Viral Tropism | 1 | 2022 | 4 | 0.190 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 242 | 0.190 |
Why?
|
| Animals | 8 | 2023 | 3238 | 0.180 |
Why?
|
| Virus Replication | 3 | 2020 | 41 | 0.170 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2020 | 2 | 0.170 |
Why?
|
| Interleukin-8 | 1 | 2020 | 14 | 0.170 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 33 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factors | 1 | 2020 | 2 | 0.170 |
Why?
|
| Virus Release | 1 | 2020 | 3 | 0.170 |
Why?
|
| Glycoproteins | 1 | 2020 | 41 | 0.170 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 4 | 0.160 |
Why?
|
| RNA Virus Infections | 1 | 2020 | 4 | 0.160 |
Why?
|
| RNA Viruses | 1 | 2020 | 4 | 0.160 |
Why?
|
| Cell Line | 3 | 2020 | 250 | 0.160 |
Why?
|
| Salicylates | 1 | 2020 | 6 | 0.160 |
Why?
|
| DNA Viruses | 1 | 2020 | 5 | 0.160 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 13 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2020 | 68 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 34 | 0.160 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 15 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2020 | 65 | 0.160 |
Why?
|
| Hippocampus | 1 | 2020 | 182 | 0.150 |
Why?
|
| Mice, Inbred NOD | 4 | 2022 | 24 | 0.150 |
Why?
|
| Mice, SCID | 4 | 2022 | 40 | 0.150 |
Why?
|
| Macrophages | 2 | 2022 | 88 | 0.140 |
Why?
|
| Methamphetamine | 1 | 2017 | 22 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 39 | 0.130 |
Why?
|
| Glutamic Acid | 1 | 2016 | 21 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 84 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 88 | 0.120 |
Why?
|
| Transcription Factor 4 | 2 | 2014 | 8 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 92 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 224 | 0.110 |
Why?
|
| Neurons | 1 | 2017 | 271 | 0.110 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 186 | 0.110 |
Why?
|
| Leukocytes | 1 | 2014 | 30 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 5 | 0.110 |
Why?
|
| Virus Integration | 1 | 2013 | 6 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 6 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 11 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 23 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 42 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 15 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 109 | 0.100 |
Why?
|
| Estradiol | 1 | 2013 | 51 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 81 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 16 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2012 | 88 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2020 | 277 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 72 | 0.090 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2022 | 5 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 2 | 2020 | 13 | 0.070 |
Why?
|
| Transfection | 2 | 2016 | 119 | 0.050 |
Why?
|
| Lamivudine | 1 | 2023 | 6 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 105 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 512 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2023 | 125 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2016 | 280 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2022 | 2 | 0.050 |
Why?
|
| Proviruses | 1 | 2022 | 3 | 0.050 |
Why?
|
| Receptors, CXCR3 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | 1 | 2022 | 2 | 0.050 |
Why?
|
| Virus Activation | 1 | 2022 | 10 | 0.050 |
Why?
|
| Mitochondria | 1 | 2022 | 54 | 0.050 |
Why?
|
| Apoptosis | 1 | 2022 | 195 | 0.040 |
Why?
|
| Binding Sites | 2 | 2012 | 67 | 0.040 |
Why?
|
| Base Sequence | 2 | 2012 | 100 | 0.040 |
Why?
|
| Protein Binding | 2 | 2012 | 114 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 5 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 45 | 0.040 |
Why?
|
| DNA Replication | 1 | 2020 | 10 | 0.040 |
Why?
|
| Virion | 1 | 2020 | 12 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2020 | 16 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 39 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 60 | 0.040 |
Why?
|
| Male | 3 | 2020 | 12260 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 557 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 17 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2017 | 15 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 19 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 24 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 26 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Morpholinos | 1 | 2016 | 3 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 19 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 36 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 76 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 6826 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 16 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 28 | 0.030 |
Why?
|
| Rats | 1 | 2017 | 625 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 76 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2014 | 11 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 18 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 11 | 0.030 |
Why?
|
| HIV | 1 | 2014 | 39 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2014 | 72 | 0.030 |
Why?
|
| Leukocyte Transfusion | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 9 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 20 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 31 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2014 | 164 | 0.030 |
Why?
|
| Female | 2 | 2020 | 12734 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 5 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2010 | 3 | 0.020 |
Why?
|
| Lithium Chloride | 1 | 2010 | 3 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 12 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 102 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 130 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 130 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 174 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 144 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 1855 | 0.020 |
Why?
|